Seaport Therapeutics SPTX
$18.05 −$0.27 (-1.47%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $18.05 0.00%
Open$18.02
Prev close$18.32
Day range$17.41 – $18.83
Volume284.3K
Market cap$966.23M
P/E (TTM)–
Dividend yield–
SPTX Stock News
Headlines matching Seaport Therapeutics or the SPTX ticker, most recent first.
- Citi Maintains Seaport Therapeutics(SPTX.US) With Buy Rating, Maintains Target Price $35
- H.C. Wainwright Maintains Seaport Therapeutics(SPTX.US) With Buy Rating, Maintains Target Price $50
- JonesTrading Maintains Seaport Therapeutics(SPTX.US) With Buy Rating, Maintains Target Price $32
- Analysts Conflicted on These NA Names: SailPoint, Inc. (SAIL) and Seaport Therapeutics, Inc. (SPTX)
- Analysts Offer Insights on NA Companies: Seaport Therapeutics, Inc. (SPTX), Navan, Inc. Class A (NAVN) and International Business Machines (IBM)
- JonesTrading Initiates Seaport Therapeutics(SPTX.US) With Buy Rating, Announces Target Price $32
- Stifel Maintains Seaport Therapeutics(SPTX.US) With Buy Rating, Maintains Target Price $30
- Seaport Therapeutics, Inc. (SPTX) Gets a Buy From Stifel Nicolaus
- Wolfe Research Initiates Seaport Therapeutics(SPTX.US) With Hold Rating
- H.C. Wainwright Initiates Seaport Therapeutics(SPTX.US) With Buy Rating, Announces Target Price $50
- J.P. Morgan Maintains Seaport Therapeutics(SPTX.US) With Buy Rating, Maintains Target Price $42
- Analysts Are Bullish on Top NA Stocks: Alamar Biosciences, Inc. (ALMR), Seaport Therapeutics, Inc. (SPTX) Positive
- Citi Sticks to Its Buy Rating for Seaport Therapeutics, Inc. (SPTX)
- Leerink Partners Maintains Seaport Therapeutics(SPTX.US) With Buy Rating, Maintains Target Price $35
- J.P. Morgan Initiates Seaport Therapeutics(SPTX.US) With Buy Rating, Announces Target Price $42
No comments yet — be the first to weigh in on SPTX.
Sign in to join the discussion.